Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate ...

Financial services firms are using tools to help customers absorb information at their own pace, the Financial Conduct ...

District 49 Board of Education members approved approximately $1.8M in cuts in this February 12 meeting. This includes the ...

CDE is the global leader in materials wet processing technology, with almost 2,000 wet processing projects delivered in over 100 countries across the world. Through it’s purpose “Championing ...

Coeur Mining transitions from heavy capex to harvest mode, delivering record Q4 2025 revenue and FCFs after Rochester expansion and Las Chispas integration. CDE posted 2025 adjusted EBITDA of $1.0Bn ...

Public services are very large and complex institutions, and reforming them can be very expensive. The two best options for funding reform (which are not mutually exclusive) are through a dividend ...

Krebs disclosed that 2026 guidance expects a 10% year-over-year increase in silver production, reflecting a full year of Las Chispas and further improvements at Rochester. He stated, "Silver is ...

Our record fourth quarter results capped off an incredible year for the company that was full of all-time bests and record achievements. I want to take a couple of minutes to run through a few of them ...

Full Year Silver Production Increase: 57% year over year. Full Year Gold Production Increase: 23% year over year. Full Year EBITDA: Increased 200% to over $1 billion. Full Year Free Cash Flow: ...

Coeur Mining (CDE) surged 258% over the past year as silver broke through $80 and joined the U.S. Critical Minerals list. We expect Coeur Mining to release their earnings tonight at about 4:30 p.m. ET ...